4
MARKET OVERVIEW
Highlights the market structure, growth drivers, restraints, and near-term inflection points influencing performance.
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
5
INDUSTRY TRENDS
Outlines emerging trends, technology impact, and regulatory signals affecting growth trajectory and stakeholder decisions.
5.1
PORTER’S FIVE FORCES ANALYSIS
5.2
MACROECONOMIC OUTLOOK
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN GLOBAL HEALTHCARE INDUSTRY
5.2.4
TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY
5.3
SUPPLY CHAIN ANALYSIS
5.6.1
AVERAGE SELLING PRICE TREND OF BODY COMPOSITION ANALYZERS OFFERED BY KEY PLAYERS, BY PRODUCT, 2023–2025
5.6.2
AVERAGE SELLING PRICE TREND OF BODY COMPOSITION ANALYZERS, BY REGION, 2023–2025
5.7.1
IMPORT SCENARIO (HS CODE 901819 AND 903180)
5.7.2
EXPORT SCENARIO (HS CODE 901819 AND 903180)
5.8
KEY CONFERENCES AND EVENTS, 2026–2027
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.10
INVESTMENT AND FUNDING SCENARIO
5.11
SUCCESS STORIES AND REAL-WORLD APPLICATIONS
5.12
IMPACT OF US TARIFFS – BODY COMPOSITION ANALYZERS MARKET
5.12.3
PRICE IMPACT ANALYSIS
5.12.4
IMPACT ON COUNTRIES/REGIONS
5.12.5
IMPACT ON END USERS
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1
KEY EMERGING TECHNOLOGIES
6.1.1
MULTI-FREQUENCY BIOELECTRICAL IMPEDANCE ANALYSIS (MF-BIA)
6.1.2
AI-ENABLED & CLOUD-CONNECTED BODY COMPOSITION ANALYSIS
6.2
COMPLEMENTARY TECHNOLOGIES
6.2.1
DUAL-ENERGY X-RAY ABSORPTIOMETRY (DEXA/DXA)
6.2.2
AIR DISPLACEMENT PLETHYSMOGRAPHY (ADP)
6.3
ADJACENT TECHNOLOGIES
6.3.1
3D OPTICAL BODY SCANNING SYSTEMS
6.3.2
SMARTPHONE-BASED BODY COMPOSITION ASSESSMENT & DIGITAL HEALTH PLATFORMS
6.4
TECHNOLOGY/PRODUCT ROADMAP
6.7
IMPACT OF AI/GEN AI ON BODY COMPOSITION ANALYZERS MARKET
6.7.1
TOP USE CASES AND MARKET POTENTIAL
6.7.2
BEST PRACTICES FOLLOWED BY MANUFACTURERS IN BODY COMPOSITION ANALYZERS MARKET
6.7.3
CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION IN BODY COMPOSITION ANALYZERS MARKET
6.7.4
INTERCONNECTED ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.7.5
CLIENTS’ READINESS TO ADOPT AI/GEN AI-INTEGRATED BODY COMPOSITION ANALYZERS
7
REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
REGIONAL REIMBURSEMENT SCENARIO
7.2.1
REIMBURSEMENT SCENARIO FOR BODY COMPOSITION ANALYZERS MARKET
7.3
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
7.4
CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8
CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
8.3
ADOPTION BARRIERS AND INTERNAL CHALLENGES
8.4
UNMET NEEDS OF VARIOUS END USERS
9
BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN UNITS)
9.2
GLOBAL VOLUME ANALYSIS OF BODY COMPOSITION ANALYZER PRODUCTS, 2024–2031 (THOUSAND UNITS)
9.3
BIOIMPEDANCE ANALYZERS
9.3.1
MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS
9.3.2
SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS
9.3.3
DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS
9.4
DUAL-ENERGY X-RAY ABSORPTIOMETRY EQUIPMENT
9.6
AIR DISPLACEMENT PLETHYSMOGRAPHY EQUIPMENT
9.7
HYDROSTATIC WEIGHING EQUIPMENT
10
BODY COMPOSITION ANALYZERS MARKET, BY MODALITY (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN UNITS)
11
BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN UNITS)
12
BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION)
12.2
SEGMENTAL BODY MEASUREMENT
12.3
WHOLE-BODY MEASUREMENT
14
BODY COMPOSITION ANALYZERS MARKET, BY END USER (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION)
14.2
FITNESS CLUBS & WELLNESS CENTERS
14.4
ACADEMIC & RESEARCH CENTERS
15
BODY COMPOSITION ANALYZERS MARKET, BY REGION (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN UNITS)
15.2.1
NORTH AMERICA VOLUME ANALYSIS – 2024–2031 (UNITS)
15.2.2
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
15.3.1
EUROPE VOLUME ANALYSIS – 2024–2031 (UNITS)
15.3.2
MACROECONOMIC OUTLOOK FOR EUROPE
15.4.1
ASIA PACIFIC VOLUME ANALYSIS – 2024–2031 (UNITS)
15.4.2
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
15.4.8
REST OF ASIA PACIFIC
15.5.1
LATIN AMERICA VOLUME ANALYSIS – 2024–2031 (UNITS)
15.5.2
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
15.5.5
REST OF LATIN AMERICA
15.6
MIDDLE EAST & AFRICA
15.6.1
MIDDLE EAST & AFRICA VOLUME ANALYSIS – 2024–2031 (UNITS)
15.6.2
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
15.6.3.3
OTHER GCC COUNTRIES
15.6.4
REST OF MIDDLE EAST & AFRICA
16.2
KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2023–2026
16.3
REVENUE ANALYSIS, 2021–2025
16.4
MARKET SHARE ANALYSIS,
16.4.1
US MARKET SHARE ANALYSIS,
16.4.2
EUROPE MARKET SHARE ANALYSIS,
16.6
BRAND/PRODUCT COMPARISON
16.7
COMPANY EVALUATION MATRIX: KEY PLAYERS,
16.7.5
COMPANY FOOTPRINT: KEY PLAYERS,
16.7.5.1
COMPANY FOOTPRINT
16.7.5.2
REGION FOOTPRINT
16.7.5.3
PRODUCT FOOTPRINT
16.7.5.4
MODALITY FOOTPRINT
16.7.5.5
USAGE TYPE FOOTPRINT
16.8
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
16.8.1
PROGRESSIVE COMPANIES
16.8.2
RESPONSIVE COMPANIES
16.8.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
16.8.5.1
DETAILED LIST OF KEY STARTUPS/SMES
16.8.5.2
COMPETITIVE BENCHMARKING OF STARTUPS/SMES
16.9
COMPANY VALUATION AND FINANCIAL METRICS
16.10
COMPETITIVE SCENARIO
16.10.4
OTHER DEVELOPMENTS
17.1.5
TANITA CORPORATION
17.1.8
SELVAS HEALTHCARE, INC.
17.1.11
IMPEDIMED LIMITED
17.1.12
CHARDER ELECTRONIC CO., LTD.
17.1.16
A&D COMPANY, LIMITED
17.2.1
MALTRON INTERNATIONAL LTD.
17.2.4
BIODYNAMICS CORPORATION
17.2.5
MICROLIFE CORPORATION
17.2.7
TONGYONG TIZHI HEALTH TECHNOLOGY CO., LTD.
17.2.8
FOOK TIN TECHNOLOGIES LTD.
17.2.11
SHANGHAI GOLDENWELL MEDICAL TECHNOLOGY CO., LTD
18.1.1.1
LIST OF KEY SECONDARY SOURCES
18.1.1.2
KEY DATA FROM SECONDARY SOURCES
18.1.2.1
KEY DATA FROM PRIMARY SOURCES
18.1.2.2
LIST OF PRIMARY INTERVIEW PARTICIPANTS
18.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
18.1.2.4
KEY INDUSTRY INSIGHTS
18.2
MARKET SIZE ESTIMATION
18.2.1
APPROACH 1: COMPANY REVENUE ANALYSIS APPROACH
18.2.2
APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION
18.2.3
APPROACH 3: BOTTOM-UP APPROACH
18.2.4
APPROACH 4: TOP-DOWN APPROACH
18.2.5
APPROACH 5: PRIMARY INTERVIEWS
18.2.6
APPROACH 6: DEMAND-SIDE APPROACH
18.2.7
APPROACH 7: VOLUME DATA ANALYSIS
18.3
MARKET FORECAST APPROACH
18.6
RESEARCH ASSUMPTIONS
18.7
RESEARCH LIMITATIONS
19.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
19.3
CUSTOMIZATION OPTIONS
19.3.2
COMPANY INFORMATION
19.3.3
GEOGRAPHIC ANALYSIS
19.3.4
REGIONAL/COUNTRY LEVEL MARKET SHARE ANALYSIS
19.3.5
COUNTRY LEVEL VOLUME ANALYSIS
19.3.6
BY PRODUCT MARKET SHARE ANALYSIS (TOP FIVE PLAYERS)
19.3.7
ANY CONSULTS/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS
Growth opportunities and latent adjacency in Body Composition Analyzers Market